{{Rsnum
|rsid=12207186
|Gene=PARK2
|Chromosome=6
|position=161893889
|Orientation=plus
|GMAF=0.09458
|Gene_s=PARK2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 90.8 | 9.2 | 0.0
| HCB | 64.4 | 28.9 | 6.7
| JPT | 62.2 | 33.3 | 4.4
| YRI | 87.1 | 12.9 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 64.4 | 28.9 | 6.7
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=T
  |Pval=5E-6
  |OR=.29
  |ORtxt=[0.16-0.41] unit decrease
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}